Singapore markets close in 3 hours 35 minutes

PAVmed Inc. (PAVMW)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.0290+0.0149 (+105.67%)
At close: 01:36PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.0141
Open1.3700
Bid1.2300 x 1000
Ask1.4000 x 1100
Day's range0.0200 - 0.0290
52-week range0.0200 - 4.7430
Volume32,626
Avg. volume6,563
Market cap769,747
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    PAVmed to Hold a Business Update Conference Call and Webcast on March 27, 2024

    PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced that it will host a business update conference call and webcast on Wednesday, March 27, 2024, at 8:30 AM ET. During the call, Lishan Aklog, M.D., PAVmed's Chairman and Chief Executive Officer, will provide a business update including an overview of the Company's operations and growth str

  • PR Newswire

    Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 26, 2024

    Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ), today announced that it will host a business update conference call and webcast on Tuesday, March 26, 2024, at 8:30 AM ET. During the call, Lishan Aklog, M.D., Lucid's Chairman and Chief Executive Officer, will provide a business update, including an overview of the Company's operations and continued

  • Simply Wall St.

    PAVmed Inc.'s (NASDAQ:PAVM) Intrinsic Value Is Potentially 66% Above Its Share Price

    Key Insights Using the 2 Stage Free Cash Flow to Equity, PAVmed fair value estimate is US$4.94 PAVmed's US$2.98 share...